Vice President; Global Head of Epidemiology
Johnson & Johnson
Cambridge, Massachusetts, United States
Joshua J Gagne, PharmD, ScD, FISPE is Vice President and Global Head of Epidemiology at Johnson & Johnson. His work over the last 15 years has focused on developing, evaluating, and applying novel methods, tools, and systems for using healthcare claims data, electronic health records, and other real-world data sources to monitor the use and outcomes of drugs, biologics, and medical devices. Josh is a faculty member in the Department of Epidemiology at the Harvard T.H. Chan School of Public Health, where he has developed courses in pharmacoepidemiology and real world evidence generation. He is a Fellow of the International Society for Pharmacoepidemiology and serves on the Editorial Boards of Pharmacoepidemiology and Drug Safety and of Drug Safety.
Eli Lilly and Company (Research Grant includes principal investigator, collaborator or consultant and pending grants as well as grants already received)Johnson and Johnson (Employment)Novartis Pharmaceuticals Corporation (Research Grant includes principal investigator, collaborator or consultant and pending grants as well as grants already received)Optum, Inc. (Consultant/Advisory Board)
Wednesday, August 24, 2022
2:00 PM – 6:00 PM CEST
Friday, August 26, 2022
1:30 PM – 3:00 PM CEST
Friday, August 26, 2022
2:30 PM – 2:45 PM CEST